Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 20.88%7.64B | ---- | 29.76%13.61B | ---- | 16.60%6.32B | ---- | -4.99%10.49B | --7.93B | --5.42B |
| Profit adjustment | ||||||||||
| Dividend (income)- adjustment | ---- | -219.25%-1.36M | ---- | 58.78%-1.01M | ---- | 83.20%-426K | ---- | 82.35%-2.44M | ---2.98M | ---2.54M |
| Attributable subsidiary (profit) loss | ---- | -42.00%36.3M | ---- | 4.21%70.02M | ---- | 364.04%62.58M | ---- | 990.05%67.19M | --44.14M | --13.49M |
| Impairment and provisions: | ---- | -145.58%-73.46M | ---- | 293.35%601.11M | ---- | 351.86%161.18M | ---- | -83.96%152.82M | ---31.13M | ---64M |
| -Impairmen of inventory (reversal) | ---- | 3,234.15%43.64M | ---- | 126.99%141.62M | ---- | -35.39%1.31M | ---- | 13.00%62.39M | --3.01M | --2.03M |
| -Other impairments and provisions | ---- | -173.25%-117.1M | ---- | 408.13%459.49M | ---- | 342.15%159.87M | ---- | -89.93%90.43M | ---34.14M | ---66.02M |
| Revaluation surplus: | ---- | -22.90%-293.34M | ---- | 3.74%-509.72M | ---- | 17.80%-238.69M | ---- | 19.88%-529.51M | ---479.62M | ---290.38M |
| -Other fair value changes | ---- | -22.90%-293.34M | ---- | 3.74%-509.72M | ---- | 17.80%-238.69M | ---- | 19.88%-529.51M | ---479.62M | ---290.38M |
| Asset sale loss (gain): | ---- | -316.24%-734.06M | ---- | 53.34%-110.01M | ---- | 1.09%-176.35M | ---- | 10.33%-235.75M | ---196.99M | ---178.3M |
| -Loss (gain) from sale of subsidiary company | ---- | -475.15%-789.43M | ---- | 41.23%-170.24M | ---- | 43.53%-137.26M | ---- | 8.11%-289.65M | ---266.94M | ---243.04M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 241.61%55.37M | ---- | 11.76%60.23M | ---- | -160.39%-39.1M | ---- | 3.03%53.89M | --69.95M | --64.74M |
| Depreciation and amortization: | ---- | -6.74%8.2B | ---- | 0.08%17.33B | ---- | 3.43%8.79B | ---- | 6.64%17.32B | --12.89B | --8.5B |
| -Depreciation | ---- | -9.34%4.86B | ---- | 4.23%10.53B | ---- | 11.41%5.36B | ---- | 12.92%10.11B | --7.42B | --4.81B |
| -Other depreciation and amortization | ---- | -61.85%-33.04M | ---- | 5.86%-43.24M | ---- | 25.80%-20.42M | ---- | -22.77%-45.94M | ---35.41M | ---27.52M |
| Financial expense | ---- | -24.58%928.36M | ---- | 4.57%2.37B | ---- | 12.65%1.23B | ---- | 10.48%2.27B | --1.68B | --1.09B |
| Special items | ---- | -257.66%-22.01M | ---- | -70.44%91.45M | ---- | -90.90%13.96M | ---- | 182.31%309.34M | --192.45M | --153.46M |
| Adjustment items | ---- | -61.85%-33.04M | ---- | 5.86%-43.24M | ---- | 25.80%-20.42M | ---- | -22.77%-45.94M | ---35.41M | ---27.52M |
| Operating profit before the change of operating capital | ---- | -3.09%15.64B | ---- | 12.15%33.41B | ---- | 10.45%16.14B | ---- | 1.28%29.79B | --21.99B | --14.62B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 189.13%106.31M | ---- | 101.72%8.44M | ---- | -35.62%-119.28M | ---- | -23.70%-491.31M | ---218.31M | ---87.95M |
| Accounts receivable (increase)decrease | ---- | -329.55%-2.06B | ---- | 5.82%-247.21M | ---- | -76.01%896.44M | ---- | -102.98%-262.5M | --2.23B | --3.74B |
| Accounts payable increase (decrease) | ---- | 183.03%1.42B | ---- | 188.76%2.19B | ---- | 32.67%-1.71B | ---- | 1,554.31%759M | ---792.61M | ---2.53B |
| Cash from business operations | ---- | -0.69%15.11B | ---- | 18.69%35.36B | ---- | -3.29%15.21B | ---- | -21.13%29.8B | --23.2B | --15.73B |
| Other taxs | ---- | -45.63%-2.17B | ---- | 1.50%-3.18B | ---- | 21.76%-1.49B | ---- | 36.46%-3.23B | ---2.23B | ---1.91B |
| Adjustment items of business operations | -13.91%19.42B | ---- | -14.21%4.06B | ---- | --22.55B | ---- | --4.73B | ---- | ---- | ---- |
| Net cash from operations | -13.91%19.42B | -5.72%12.94B | -14.21%4.06B | 21.14%32.19B | 7.51%22.55B | -0.74%13.72B | 9.97%4.73B | -18.75%26.57B | --20.98B | --13.82B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | -8.12%550.02M | 4.52%404.86M | 79.78%123M | 6.95%854.15M | -4.93%598.66M | -10.65%387.34M | -58.95%68.42M | -12.54%798.63M | --629.73M | --433.49M |
| Sale of fixed assets | -36.78%150M | -57.04%77.06M | -30.38%27.81M | -7.76%309.78M | 22.58%237.26M | 49.71%179.38M | -57.86%39.94M | 90.45%335.83M | --193.56M | --119.82M |
| Purchase of fixed assets | 2.59%-6.67B | 18.46%-4.14B | 41.77%-1.91B | 25.07%-9.34B | 19.09%-6.85B | 6.95%-5.08B | -12.04%-3.28B | 12.07%-12.47B | ---8.47B | ---5.45B |
| Sale of subsidiaries | 1,167.36%1.91B | 285.70%1.91B | -93.49%10M | 3.48%882.04M | -77.54%150.65M | 36.98%495.3M | 3,163.83%153.6M | -26.22%852.37M | --670.71M | --361.59M |
| Acquisition of subsidiaries | 96.57%-21.84M | -85.69%-1.17B | 97.21%-17.31M | 69.36%-725.04M | 40.63%-636.54M | 33.45%-628.53M | -527.63%-620.11M | 29.13%-2.37B | ---1.07B | ---944.49M |
| Recovery of cash from investments | -37.00%251.29M | 78.23%50.6B | 9.56%11.68M | -7.95%86.15B | -99.44%398.87M | -42.20%28.39B | -99.95%10.66M | -39.83%93.6B | --70.6B | --49.12B |
| Cash on investment | -1,705.41%-1.57B | -67.94%-66.35B | -7,009.61%-1.13B | 3.98%-90.5B | 99.89%-86.78M | 31.01%-39.51B | 99.95%-15.82M | 38.14%-94.25B | ---80.56B | ---57.27B |
| Other items in the investment business | 20.65%-13.77B | 262.92%1.15B | -0.34%-4.5B | --316.66M | ---17.36B | --316.66M | ---4.48B | ---- | ---- | ---- |
| Net cash from investment operations | 18.57%-19.17B | -13.42%-17.52B | 9.22%-7.38B | 10.74%-12.05B | -30.78%-23.55B | -13.28%-15.44B | 42.59%-8.13B | -11.70%-13.51B | ---18B | ---13.63B |
| Net cash before financing | 124.32%241.55M | -165.94%-4.58B | 2.28%-3.32B | 54.10%20.13B | -133.41%-993.27M | -1,000.60%-1.72B | 65.55%-3.4B | -36.62%13.06B | --2.97B | --191.24M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -21.79%24B | -19.35%15.8B | -34.98%9.54B | -2.27%31.85B | 10.11%30.69B | 25.40%19.58B | 51.37%14.67B | 17.70%32.59B | --27.87B | --15.62B |
| Refund | 11.81%-29.24B | -19.72%-18.77B | -77.74%-11.11B | -81.48%-42.28B | -104.57%-33.15B | -47.81%-15.68B | -25.56%-6.25B | 26.35%-23.3B | ---16.21B | ---10.61B |
| Issuing shares | ---- | ---- | ---- | --5.32B | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance of bonds | ---- | -24.21%2.5B | ---- | 186.53%4.3B | ---- | 119.91%3.3B | ---- | -87.38%1.5B | --1.5B | --1.5B |
| Interest paid - financing | ---- | 29.73%-669.4M | ---- | 0.07%-1.82B | ---- | -11.84%-952.57M | ---- | -25.36%-1.82B | ---1.29B | ---851.71M |
| Dividends paid - financing | -28.45%-5.79B | 89.73%-315.31M | 18.37%-365.45M | -447.55%-9.93B | -157.57%-4.51B | -92.03%-3.07B | -7,605.25%-447.68M | 18.93%-1.81B | ---1.75B | ---1.6B |
| Absorb investment income | 8,974.42%2.99B | 13.22%31.67M | 302.40%91.02M | -80.76%30.23M | -76.30%32.93M | -50.84%27.97M | -30.27%22.62M | -3.44%157.08M | --138.95M | --56.89M |
| Issuance expenses and redemption of securities expenses | ---- | 7.97%-2.15B | ---- | 58.96%-4.54B | ---- | 53.84%-2.34B | ---- | -27.24%-11.07B | ---9.57B | ---5.06B |
| Other items of the financing business | 43.54%-6.34B | 95.63%-146.22M | 64.64%-1.54B | -135.42%-3.47B | -704.03%-11.22B | -2,550.65%-3.35B | -297,662.00%-4.36B | 62.30%-1.47B | ---1.4B | ---126.29M |
| Net cash from financing operations | 20.85%-14.38B | -17.78%-7.28B | -192.90%-3.38B | -115.31%-27.98B | -180.15%-18.16B | -24.54%-6.18B | 333.48%3.64B | 18.87%-12.99B | ---6.48B | ---4.96B |
| Effect of rate | 1,437.13%43.47M | -50.67%-42.45M | -100.51%-1.16M | -54.24%45.23M | -72.06%2.83M | -122.17%-28.17M | 280.38%228.19M | -88.66%98.84M | --10.12M | --127.05M |
| Net Cash | 26.22%-14.13B | -50.06%-11.86B | -2,829.09%-6.7B | -11,388.58%-7.85B | -445.62%-19.16B | -65.62%-7.9B | 102.72%245.54M | -98.49%69.52M | ---3.51B | ---4.77B |
| Begining period cash | -19.29%32.65B | -19.29%32.65B | -19.29%32.65B | 0.42%40.45B | 0.42%40.45B | 0.42%40.45B | 0.42%40.45B | 15.70%40.28B | --40.28B | --40.28B |
| Cash at the end | -12.86%18.56B | -36.21%20.74B | -36.60%25.94B | -19.29%32.65B | -42.10%21.29B | -8.75%32.52B | 31.42%40.92B | 0.42%40.45B | --36.78B | --35.63B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.